Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Melatonin vs Pinealon: Research Comparison

The following table directly compares melatonin vs Pinealon across key research parameters. Researchers frequently compare these compounds due to their historical association with pineal gland function, but their structural classification, mechanism, and appro

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • The following table directly compares melatonin vs Pinealon across key research parameters. Researchers frequently compare these compounds due to their historical association with pineal gland function, but their structural classification, mechanism, and appropriate study endpoints differ fundamentally.
  • Compound Class
  • Indoleamine hormone (tryptophan derivative)
  • Synthetic tripeptide (Glu-Asp-Arg)
  • Non-comparable compound types requiring distinct experimental protocols
  • Molecular Weight
  • 232.28 g/mol
  • ~389 g/mol
  • Size difference affects bioavailability and delivery route selection
  • Primary Mechanism
  • MT1/MT2 receptor agonist in SCN; direct antioxidant via radical scavenging
  • Gene expression modulation through DNA interaction; telomerase upregulation
  • Melatonin = receptor-mediated signaling; Pinealon = epigenetic regulation
  • Half-Life
  • 20–50 minutes (plasma)
  • Effects persist weeks post-administration (gene expression changes)
  • Duration of action differs by three orders of magnitude
  • Research Application
  • Circadian rhythm entrainment, sleep architecture, jet lag, oxidative stress models
  • Neuroprotection, age-related cognitive decline, neurodegeneration, cellular senescence
  • Melatonin for acute circadian/sleep studies; Pinealon for long-term neurodegeneration models
  • Typical Dose (Human)
  • 0.3–10mg oral/sublingual
  • 10mg IM/SC daily × 10–20 days
  • Melatonin allows flexible acute dosing; Pinealon requires cycle-based protocols
  • Study Endpoint Timeline
  • Hours to weeks
  • Months to years
  • Timeline mismatch makes direct comparison protocols impractical
  • Regulatory Status
  • Available as supplement; hormone classification varies by jurisdiction
  • Research peptide; no FDA approval for human use; available through 503B synthesis
  • Melatonin more accessible; Pinealon restricted to research contexts

Related resources

More comparisons